Sialyl Lea-KLH conjugate vaccine (Memorial Sloan-Kettering Cancer Center)

N/A

Report date: 2023/02/17 21:17:32

Base Information

Drug NameSialyl Lea-KLH conjugate vaccine (Memorial Sloan-Kettering Cancer Center)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Conjugated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMabvax Therapeutics IncMemorial Sloan Kettering Cancer Center
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A